Concord Biotech Limited — Important, 02-05-2025: General Updates
02-05-2025 | 05:29 pm
02-05-2025 | 05:29 pm
Concord Biotech has announced a board meeting to consider the financial results for the quarter and half-year. The USFDA inspection of their Dholka API facility resulted in four procedural observations without data integrity issues. The company aims to address these swiftly, with no immediate financial impact expected.
No comments yet. Be the first to comment!
